Stephany Verstraete Sells 506 Shares of Teladoc Health, Inc. (NYSE:TDOC) Stock

Teladoc Health, Inc. (NYSE:TDOCGet Free Report) CMO Stephany Verstraete sold 506 shares of the stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $22.89, for a total transaction of $11,582.34. Following the transaction, the chief marketing officer now owns 42,222 shares in the company, valued at approximately $966,461.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $22.58 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.45 and a quick ratio of 3.36. The firm has a fifty day moving average price of $24.36 and a 200-day moving average price of $24.98. Teladoc Health, Inc. has a 1 year low of $21.21 and a 1 year high of $34.73.

Teladoc Health (NYSE:TDOCGet Free Report) last posted its quarterly earnings results on Tuesday, July 25th. The health services provider reported ($0.40) EPS for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.04. The business had revenue of $652.41 million for the quarter, compared to analysts’ expectations of $649.20 million. Teladoc Health had a negative return on equity of 7.32% and a negative net margin of 158.76%. During the same period last year, the firm earned ($0.44) earnings per share. The business’s quarterly revenue was up 10.1% on a year-over-year basis. Analysts anticipate that Teladoc Health, Inc. will post -1.36 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on TDOC shares. started coverage on shares of Teladoc Health in a research note on Thursday, August 17th. They set a “sell” rating for the company. Citigroup reduced their price objective on Teladoc Health from $31.00 to $29.00 in a research report on Wednesday, July 26th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and six have issued a buy rating to the company. According to MarketBeat, Teladoc Health has a consensus rating of “Hold” and a consensus price target of $31.20.

Read Our Latest Research Report on TDOC

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. MetLife Investment Management LLC purchased a new position in shares of Teladoc Health in the first quarter worth $218,000. Panagora Asset Management Inc. increased its holdings in Teladoc Health by 18.8% in the 1st quarter. Panagora Asset Management Inc. now owns 16,710 shares of the health services provider’s stock valued at $1,205,000 after acquiring an additional 2,640 shares during the last quarter. Rhumbline Advisers increased its holdings in Teladoc Health by 2.3% in the 1st quarter. Rhumbline Advisers now owns 130,916 shares of the health services provider’s stock valued at $9,443,000 after acquiring an additional 2,921 shares during the last quarter. Great West Life Assurance Co. Can lifted its stake in Teladoc Health by 10.8% in the 1st quarter. Great West Life Assurance Co. Can now owns 107,908 shares of the health services provider’s stock worth $8,237,000 after purchasing an additional 10,559 shares in the last quarter. Finally, Raymond James Trust N.A. boosted its holdings in shares of Teladoc Health by 7.8% during the 1st quarter. Raymond James Trust N.A. now owns 11,451 shares of the health services provider’s stock valued at $826,000 after purchasing an additional 827 shares during the last quarter. 77.07% of the stock is currently owned by institutional investors.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

See Also

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with's FREE daily email newsletter.